株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管インターベンション:末梢血管疾患治療用デバイス

Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices

発行 Datamonitor Healthcare 商品コード 858315
出版日 ページ情報 英文 107 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
心血管インターベンション:末梢血管疾患治療用デバイス Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices
出版日: 2018年12月22日 ページ情報: 英文 107 Pages
概要

世界の末梢血管疾患治療用デバイスの市場は予測期間中7.2%のCAGR (複合年間成長率) で推移し、2017年の41億5130万ドルから、2022年には58億7660万ドルの規模に成長すると予測されています。

当レポートでは、世界の末梢血管疾患治療用デバイスの市場を調査し、疾患の臨床的概要、治療デバイスの種類と概要、技術動向、市場成長への各種影響因子の分析、競合環境・主要事業者、地域・デバイスタイプ別の処置件数および製品売上規模の推移と予測などをまとめています。

エグゼクティブサマリー

第1章 末梢血管疾患の概要

  • 重症下肢虚血
  • 動脈瘤
  • 深部静脈血栓症/肺塞栓症
  • 診断・治療

第2章 末梢血管疾患の治療デバイス

  • 血管形成術用カテーテル
    • バルーン血管形成術用製品
    • 薬剤コーティングバルーンカテーテル製品
    • カッティング&スコアリングバルーンカテーテル製品
  • 血管ステント
    • ベアメタルステント
    • 薬剤溶出型ステント
    • 生体吸収性ステント・生体吸収性血管スキャフォールド
  • アテレクトミーカテーテル
  • 血栓塞栓除去用カテーテル
  • 慢性完全閉塞 (CTO) 治療用デバイス

第3章 治療デバイス市場の分析・予測

  • 世界市場の分析
    • 市場規模
    • 技術動向
    • 市場成長推進因子・抑制因子
    • 治療デバイスの概要
    • 市場のリーダー
    • 競合戦略
    • 新たな競合
  • 主要事業者
    • 血管形成術用カテーテル
    • 血管ステント
    • アテレクトミーカテーテル
    • 血栓除去用カテーテル
    • CTOクロッシングデバイス
  • 市場予測
    • 市場予測:米国
    • 市場予測:EU5カ国
    • 市場予測:日本
    • 市場予測:その他の地域

付録:企業リスト

目次
Product Code: #MDT18023

Overview

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for therapeutic devices for the treatment of peripheral vasclar disease (PVD). Therapeutic devices covered by the scope of this report include:

  • angioplasty catheters (POBA, DCB, cutting, and scoring balloon angioplasty catheters)
  • vascular stents (bare-metal and drug-eluting stents)
  • atherectomy catheters
  • thromboembolectomy catheters
  • chronic total occlusion crossing devices

The global market for PVD therapeutic devices is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2017-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually. Primary research querying interventional cardiologists regarding device preferences and utilization was leveraged in the formulation of this report's forecasts and analyses. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 7.2% during the 2017-22 forecast, increasing from approximately $4,151.3m in 2017 to an estimated $5,876.6m in 2022.

TABLE OF CONTENTS

Executive Summary

  • i. Peripheral vascular disease overview
  • ii. Global peripheral vascular disease therapeutic devices market
    • a. Market drivers and limiters
    • b. Device segment insights
    • c. Technology trends
    • d. Market leaders
    • e. Competitive strategies
    • f. Emerging competition
  • iii. Methodology
  • iv. Bibliography
  • Exhibit ES-1: PVD therapeutic devices, global market forecast ($m), 2017-22
  • Exhibit ES-2: Global PVD therapeutic devices market, share by country/region, 2017
  • Exhibit ES-3: Drivers and limiters of market growth - vascular access site closure products

1. Peripheral Vascular Disease Overview

  • 1.1. Critical limb ischemia
  • 1.2. Aneurysm
  • 1.3. Deep vein thrombosis/pulmonary embolism
  • 1.4. Diagnosis and treatment
  • 1.5. Bibliography
  • Exhibit 1-1: Estimated prevalence of peripheral artery disease, select countries, 2016
  • Exhibit 1-2: Estimated incident cases of DVT, select countries, 2017
  • Exhibit 1-3: Estimated incident cases of PE, select countries, 2017

2. Peripheral Vascular Disease Therapeutic Products

  • 2.1. Angioplasty catheters
    • 2.1.1. Balloon angioplasty products
    • 2.1.2. Drug-coated balloon catheter products
    • 2.1.3. Cutting and scoring balloon catheter products
  • 2.2. Vascular stents
    • 2.2.1. Bare-metal stents
    • 2.2.2. Drug-eluting stents
    • 2.2.3. Bioabsorbable stents and bioresorbable vascular scaffolds
  • 2.3. Atherectomy catheters
  • 2.4. Thromboembolectomy catheters
  • 2.5. Chronic total occlusion therapy devices
  • 2.6. Bibliography

3. Peripheral Vascular Disease Therapeutic Devices Market

  • 3.1. Global market insights
    • 3.1.1. Market value
    • 3.1.2. Technology trends
    • 3.1.3. Market drivers and limiters
    • 3.1.4. PVD therapeutic devices overview
    • 3.1.5. Market leaders
    • 3.1.6. Competitive strategies
    • 3.1.7. Emerging competition
  • 3.2. Global competitors
    • 3.2.1. Angioplasty catheters
    • 3.2.2. Vascular stents
    • 3.2.3. Atherectomy catheters
    • 3.2.4. Thrombectomy catheters
    • 3.2.5. CTO crossing devices
  • 3.3. Market forecast
    • 3.3.1. Market forecast: US
    • 3.3.2. Market forecast: five major EU markets
    • 3.3.3. Market forecast: Japan
    • 3.3.4. Market forecast: Rest of the world
  • 3.4. Bibliography
  • Exhibit 3-1: PVD therapeutic devices, global market forecast ($m), 2017-22
  • Exhibit 3-2: Global PVD therapeutic device market, market forecast ($m), by product segment, 2017-22
  • Exhibit 3-3: Global PVD therapeutic device sales, share by product segment, 2017
  • Exhibit 3-4: Global PVD therapeutic devices market, share by country/region, 2017
  • Exhibit 3-5: Global PVD therapeutic device sales, combined market forecast ($m), by country/region, 2017-22
  • Exhibit 3-6: Drivers and limiters of market growth - vascular access site closure products
  • Exhibit 3-7: Estimated average sale price, selected angioplasty catheters, 2017
  • Exhibit 3-8: Estimated average sale price, selected vascular stents, 2017
  • Exhibit 3-9: Angioplasty catheters market, share by supplier, 2017
  • Exhibit 3-10: Vascular stents market, share by supplier, 2017
  • Exhibit 3-11: Atherectomy devices market, share by supplier, 2017
  • Exhibit 3-12: Thrombectomy devices market, share by supplier, 2017
  • Exhibit 3-13: US PVD therapeutic device sales, estimated market forecast ($m), by product type, 2017-22
  • Exhibit 3-14: US percutaneous transluminal angioplasty, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-15: US percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2017-22
  • Exhibit 3-16: US peripheral vascular stent implantation, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-17: US peripheral vascular stent sales, market forecast ($m), 2017-22
  • Exhibit 3-18: US peripheral atherectomy, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-19: US peripheral atherectomy device sales, market forecast ($m), 2017-22
  • Exhibit 3-20: US peripheral thrombectomy, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-21: US peripheral thrombectomy sales, market forecast ($m), 2017-22
  • Exhibit 3-22: US chronic total occlusion, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-23: US CTO crossing device sales, market forecast ($m), 2017-22
  • Exhibit 3-24: 5EU PVD therapeutic device sales, estimated market forecast ($m), by product type, 2017-22
  • Exhibit 3-25: 5EU percutaneous transluminal angioplasty, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-26: 5EU percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2017-22
  • Exhibit 3-27: 5EU peripheral vascular stent implantation, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-28: 5EU peripheral vascular stent sales, market forecast ($m), 2017-22
  • Exhibit 3-29: 5EU peripheral atherectomy, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-30: 5EU peripheral atherectomy device sales, market forecast ($m), 2017-22
  • Exhibit 3-31: 5EU peripheral thrombectomy, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-32: 5EU peripheral thrombectomy sales, market forecast ($m), 2017-22
  • Exhibit 3-33: 5EU chronic total occlusion, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-34: 5EU CTO crossing device sales, market forecast ($m), 2017-22
  • Exhibit 3-35: Japanese PVD therapeutic device sales, estimated market forecast ($m), by product type, 2017-22
  • Exhibit 3-36: Japanese percutaneous transluminal angioplasty, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-37: Japanese percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2017-22
  • Exhibit 3-38: Japanese peripheral vascular stent implantation, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-39: Japanese peripheral vascular stent sales, market forecast ($m), 2017-22
  • Exhibit 3-40: Japanese peripheral atherectomy, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-41: Japanese peripheral atherectomy device sales, market forecast ($m), 2017-22
  • Exhibit 3-42: Japanese peripheral thrombectomy, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-43: Japanese peripheral thrombectomy sales, market forecast ($m), 2017-22
  • Exhibit 3-44: Japanese chronic total occlusion, procedure volumes forecast (000s), 2017-22
  • Exhibit 3-45: Japanese CTO crossing device sales, market forecast ($m), 2017-22
  • Exhibit 3-46: RoW PVD therapeutic device sales, estimated market forecast ($m), by product type, 2017-22
  • Exhibit 3-47: RoW percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2017-22
  • Exhibit 3-48: RoW peripheral vascular stent sales, market forecast ($m), 2017-22
  • Exhibit 3-49: RoW peripheral atherectomy device sales, market forecast ($m), 2017-22
  • Exhibit 3-50: RoW peripheral thrombectomy sales, market forecast ($m), 2017-22
  • Exhibit 3-51: RoW CTO crossing device sales, market forecast ($m), 2017-22
<>Appendix: Company Listing
Back to Top